InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
2
T+90 胜率
100%
T+90 平均收益
+30.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Evanson Jeff, Directeur Commercial. Director active across 1 company, notably Outlook Therapeutics, Inc.. Cumulatively, 4 filings have been logged. Split: 2 buys · 2 sells. Total volume traded: €372k. Activity tracked since 3 December 2021. The latest transaction was filed on 7 March 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Evanson Jeff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
62,484 股@ US$0.425.8% 占其流量Common StockSEC:0001415889-24-007516:0
标准退出：2024年6月5日 (T+90)
267,000 股@ US$1.1166.1% 占其流量Common StockSEC:0001209191-23-004732:0
27,162 股@ US$1.317.9% 占其流量Common StockSEC:0001209191-23-004118:0
35,200 股@ US$1.3411.2% 占其流量Common StockSEC:0001209191-21-068134:0
标准退出：2022年3月3日 (T+90)
4 条申报中的 4 条
About Evanson Jeff
Jeff Evanson is the Chief Commercial Officer at Outlook Therapeutics, Inc. He is responsible for business strategy and development. His role includes identifying market opportunities and managing sales teams.
